For instance, abnormal expression of PRKACB can suppress the PKA/CREB pathway, promoting tau hyperphosphorylation and brain aging [65], and is associated with colorectal and pancreatic cancers [66, 67]. Here, PRKACB is linked to familial pancreatic carcinoma.